2.5 mg to ml syringe semaglutide Weight Loss Dosage Chart: Starting, Max, and Effective Doses Hims & Hers rolls out
Description
Experts note that many patients discontinue the use of weight-loss medications due to side effects
Providers like United Healthcare, Cigna, Blue Cross Blue Shield, and others may offer coverage with specific conditions such as a BMI of 30 or higher, or 27 with weight-related health issues
Overall, while it might offer a potential tool for weight management, it should be used with realistic expectations
Zepbound (tirzepatide for obesity) launched November 2023 and went into shortage within weeks due to overwhelming demand
[1] While semaglutide itself doesn't typically cause frequent urination, certain urinary symptoms warrant prompt medical evaluation
